|
Pfizer Oncology is committed to discovering and investigating immunotherapies that aim to overcome tumor-induced immune suppression. With an increased understanding of immune regulation, novel agents targeting specific regulatory checkpoints in the immune cascade are being developed. These strategies may be generally applicable to a wide range of clinical settings, permitting the development |
 |
of platform technologies that can be used either alone or in combination with other therapies for the treatment of a wide variety of tumor types |